NCT05977140View on ClinicalTrials.gov

CDI-988 Safety Study in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

September 27, 2023

Primary Completion Date

May 23, 2025

Study Completion Date

July 23, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

CDI-988

SARS-CoV-2 3CL protease inhibitor

DRUG

Placebo

matching placebo

Trial Locations (1)

2031

Scientia Clinical Research Pty Ltd, Randwick

Sponsors
All Listed Sponsors
collaborator

Cocrystal Pharma Australia Pty Ltd.

UNKNOWN

collaborator

Beyond Drug Development Pty Ltd.

UNKNOWN

collaborator

Resolutum Global Pty Ltd.

UNKNOWN

collaborator

Scientia Clinical Research Pty Ltd

UNKNOWN

lead

Cocrystal Pharma, Inc.

INDUSTRY

NCT05977140 - CDI-988 Safety Study in Healthy Participants | Biotech Hunter | Biotech Hunter